Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12617000367347
ACTRN12617000367347
Completed
未知

Clinical and Health Economic Outcomes in Elderly Patients with an Operative Neck of Femur Fracture (CHIEF Study)

Dr Aihua Wu0 sites892 target enrollmentMarch 10, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHip FractureGeriatricAnaesthesiology - Other anaesthesiologyInjuries and Accidents - FracturesPublic Health - Health service research

Overview

Phase
未知
Intervention
Not specified
Conditions
Hip Fracture
Sponsor
Dr Aihua Wu
Enrollment
892
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 10, 2017
End Date
February 12, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dr Aihua Wu

Eligibility Criteria

Inclusion Criteria

  • •1\. Aged 70 years or older
  • •2\. Admission diagnosis was hip fracture
  • •3\. Underwent an operation to repair the hip fracture during the study period July 2011 to July 2015

Exclusion Criteria

  • •patients with a hip fracture medically managed

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Intensive Medical Treatment after Heart AttackHeart FailureCardiovascular - Other cardiovascular diseases
ACTRN12610000802000PAH200
Not yet recruiting
Phase 1
Survival of elderly patients operated for hip fractureHealth Condition 1: null- proximal femoral fracture.
CTRI/2018/03/012853PGIMER
Recruiting
Not Applicable
Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip ReplacementTotal Hip Replacement
NCT03120312Second Hospital of Shanxi Medical University1,500
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.
EUCTR2016-002272-27-BESaarland University388
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2016-002272-27-ATSaarland University388